Based on the findings of these studies, APOE ε2 and APOE ε4 may affect the cognitive function of carriers via different regulations of the same pathological process (7), thus, a direct comparison of the difference in the brain of carriers between these two genotypes may be more helpful in advancing our understanding about AD. This evidence concerns the gene APOE and Alzheimer disease.